PI3K
Nov 17, 2016
Phosphoinositide 3-Kinase (PI3k) Inhibitors: Emerging target therapies against Cancer
Phosphoinositide 3-kinases (PI3Ks) were discovered in 1980, and since then drug developers have accelerated their research funds in order to find potential drug candidate for inhibiting PI3Ks for the treatment of cancers. Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that act as intermediate signaling mol...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
